Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lee

Showing results (681-690 of 702) with videos related to

Pageof 71
Sort By:
American Heart Journal|April 15, 2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 11, 2019
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patientsJoshua P Lewis, Joshua D Backman, Jean-Luc Reny, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancerJenna H Newman, C Brent Chesson, Nora L Herzog, et al.
Journal of Medicinal Chemistry|May 30, 2013
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): metabolically stable γ-secretase Inhibitors that selectively inhibit the production of amyloid-β over NotchGary Probst, Danielle L Aubele, Simeon Bowers, et al.
Circulation|September 28, 2020
Genetic Architecture of Abdominal Aortic Aneurysm in the Million Veteran ProgramDerek Klarin, Shefali Setia Verma, Renae Judy, et al.
The New England Journal of Medicine|December 27, 2013
Variant GADL1 and response to lithium therapy in bipolar I disorderChien-Hsiun Chen, Chau-Shoun Lee, Ming-Ta Michael Lee, et al.
Science (New York, N.Y.)|August 4, 2022
Pathogenic variants damage cell composition and single cell transcription in cardiomyopathiesDaniel Reichart, Eric L Lindberg, Henrike Maatz, et al.
BMJ (Clinical Research Ed.)|September 25, 2015
Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort studyTai-Ming Ko, Chang-Youh Tsai, Shih-Yang Chen, et al.
Journal of the American College of Cardiology|March 24, 2017
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve StenosisSung-Han Yoon, Sabine Bleiziffer, Ole De Backer, et al.
Cell|August 27, 2021
Deciphering osteoarthritis genetics across 826,690 individuals from 9 populationsCindy G Boer, Konstantinos Hatzikotoulas, Lorraine Southam, et al.
Pageof 71

Showing results (681-690 of 702) with videos related to

Sort By:
Pageof 71
American Heart Journal|April 15, 2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 11, 2019
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patientsJoshua P Lewis, Joshua D Backman, Jean-Luc Reny, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancerJenna H Newman, C Brent Chesson, Nora L Herzog, et al.
Journal of Medicinal Chemistry|May 30, 2013
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): metabolically stable γ-secretase Inhibitors that selectively inhibit the production of amyloid-β over NotchGary Probst, Danielle L Aubele, Simeon Bowers, et al.
Circulation|September 28, 2020
Genetic Architecture of Abdominal Aortic Aneurysm in the Million Veteran ProgramDerek Klarin, Shefali Setia Verma, Renae Judy, et al.
The New England Journal of Medicine|December 27, 2013
Variant GADL1 and response to lithium therapy in bipolar I disorderChien-Hsiun Chen, Chau-Shoun Lee, Ming-Ta Michael Lee, et al.
Science (New York, N.Y.)|August 4, 2022
Pathogenic variants damage cell composition and single cell transcription in cardiomyopathiesDaniel Reichart, Eric L Lindberg, Henrike Maatz, et al.
BMJ (Clinical Research Ed.)|September 25, 2015
Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort studyTai-Ming Ko, Chang-Youh Tsai, Shih-Yang Chen, et al.
Journal of the American College of Cardiology|March 24, 2017
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve StenosisSung-Han Yoon, Sabine Bleiziffer, Ole De Backer, et al.
Cell|August 27, 2021
Deciphering osteoarthritis genetics across 826,690 individuals from 9 populationsCindy G Boer, Konstantinos Hatzikotoulas, Lorraine Southam, et al.
Pageof 71